Browse Category

Investment News News 21 December 2025 - 22 December 2025

ST Engineering Stock (SGX: S63) News and Forecasts on Dec 22, 2025: RHB’s S$9.40 Target, Record Order Book, Dividend Boost, and Key Risks

ST Engineering Stock (SGX: S63) News and Forecasts on Dec 22, 2025: RHB’s S$9.40 Target, Record Order Book, Dividend Boost, and Key Risks

Singapore Technologies Engineering Ltd (ST Engineering) shares were trading around S$8.34 on Dec 22, 2025, as renewed broker commentary and a busy run of contract-and-product headlines keep the counter in focus going into year-end. MarketScreener The stock’s 2025 run has
Intuit (INTU) Stock: Key News, Earnings Forecasts, and Analyst Targets to Know Before the Market Opens on Dec. 22, 2025

Intuit (INTU) Stock: Key News, Earnings Forecasts, and Analyst Targets to Know Before the Market Opens on Dec. 22, 2025

Intuit Inc. (NASDAQ: INTU) enters the Dec. 22, 2025 market open with a familiar investment debate back in focus: can the company’s “platform” strategy—spanning TurboTax, QuickBooks, Credit Karma, and Mailchimp—keep delivering durable double‑digit growth while it layers on new AI
Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (NASDAQ: FOLD) is no longer trading like a “typical biotech story stock.” After BioMarin’s all-cash $14.50-per-share takeover agreement, FOLD has effectively become a deal-driven, merger-arbitrage name—meaning next week’s action is likely
1 54 55 56 57 58 132
Go toTop